Expert authorship
Educational priorities should remain in the hands of educators and institutions rather than defaulting to generic model behavior.
About
A company shaped by academic medicine, built for better learning
Equanimity Labs grew from work in clinical education, infectious diseases, and AI systems. PRISM is our first platform: a faculty-controlled environment for turning expert content into guided, course-grounded learning.
Origin
How Equanimity Labs came together
Equanimity Labs grew out of complementary work at Johns Hopkins University. Dr. Shah’s clinical and educational leadership in infectious diseases and Dr. Clipman’s work in AI methods and systems design converged around the same practical problem: case-based clinical teaching is one of the most effective ways to teach reasoning, but it is difficult to deliver repeatedly, consistently, and at institutional scale.
We began with clinical reasoning because it demands careful sources, explicit teaching judgment, and structured feedback. We are building those principles into educational software designed for other rigorous academic and professional settings.
Why Equanimity Labs
The company name is drawn from William Osler’s idea of Aequanimitas , a concept closely associated with Johns Hopkins medicine. It reflects the tone we want the work to carry: measured, careful, and grounded in judgment rather than hype.
Source-grounded systems
Useful educational software needs clear scope, strong source grounding, and obvious operating boundaries.
Institutional fit
We build for real academic and educational settings, where operational detail matters as much as technical capability.
Faculty determine what should be taught
We build AI systems around a clear division of responsibility: faculty determine what should be taught and what good reasoning looks like; software helps deliver that teaching consistently.
Maunank Shah, MD, PhD
Dr. Shah directs infectious diseases educational activities at Johns Hopkins and serves as co-director for the microbiology and infectious disease curriculum. His prior work includes digital tools for tuberculosis and HIV care, including video-DOT and HIVASSIST. At Equanimity Labs, he leads the clinical, educational, and partnership direction of the company’s platform.
Steven Clipman, PhD, MSPH
Dr. Clipman’s work sits at the intersection of AI methods, infectious disease research, and product architecture. At Equanimity Labs, he leads platform design, technical strategy, and the AI systems work required to turn faculty-authored educational content into durable, deployable software.